Coronaviruses
Title:Vitamin D3 Deficiency and COVID-19
Volume: 2 Issue: 1
Author(s): Olen R. Brown*Martin R. Hullender
Affiliation:
- Dalton Cardiovascular Research Center, University of Missouri- Columbia, MO,United States
Export Options
About this article
Cite this article as:
Brown R. Olen *, Hullender R. Martin , Vitamin D3 Deficiency and COVID-19, Coronaviruses 2021; 2 (1) . https://dx.doi.org/10.2174/2666796701999200914112352
DOI https://dx.doi.org/10.2174/2666796701999200914112352 |
Print ISSN 2666-7967 |
Publisher Name Bentham Science Publisher |
Online ISSN 2666-7975 |
Article Metrics

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Exploring the Potential Mechanism of Shufeng Jiedu Capsule for Treating COVID-19 by Comprehensive Network Pharmacological Approaches and Molecular Docking Validation
Combinatorial Chemistry & High Throughput Screening Recent Developments in Lipid Drugs
Mini-Reviews in Medicinal Chemistry The Effect of Potato Almond Orange Cookies on their Weight, BMI, Hemoglobin, and Lymphocyte Status of Undernourished Older People during COVID-19 Pandemic
Current Nutrition & Food Science A Technological Update of Molecular Diagnostics for Infectious Diseases
Infectious Disorders - Drug Targets Characterizing the Zika Virus Genome – A Bioinformatics Study
Current Computer-Aided Drug Design The Effectiveness and Safety of Remdesivir for the Treatment of Patients With COVID-19: A Systematic Review and Meta-Analysis
Anti-Infective Agents Editorial [Hot Topic:Applications of Angiotensin Converting Enzyme Inhibitors and of Angiotensin II Receptor Blockers in Pharmacology and Therapy: An Update (Executive Editor: Agostino Molteni)]
Current Pharmaceutical Design Molecular Docking, DFT Studies and ADMET Simulations for Evaluating Already Approved FDA Drugs as Inhibitors for SARS-Cov-2 RNADependent Polymerase
Letters in Drug Design & Discovery Boosting Innate Immunity During SARS-CoV-2 Clearance
Coronaviruses Silybin B and Cianidanol Inhibit M<sup>pro</sup> and Spike Protein of SARS-CoV-2: Evidence from in silico Molecular Docking Studies
Current Pharmaceutical Design Misinformation About COVID-19 and Confidential Information Leakage: Impacts on the Psychological Well-being of Indians
Current Psychiatry Research and Reviews COVID-19: Morphology, Characteristics, Symptoms, Prevention, Clinical Diagnosis and Current Scenario
Coronaviruses An Augmented Passive Immune Therapy to Treat Fulminant Bacterial Infections
Recent Patents on Anti-Infective Drug Discovery SARS-CoV-2: Recent Reports on Antiviral Therapies Based on Lopinavir/Ritonavir, Darunavir/Umifenovir, Hydroxychloroquine, Remdesivir, Favipiravir and other Drugs for the Treatment of the New Coronavirus
Current Medicinal Chemistry Current Strategies and Approaches in Combating SARS-CoV-2 Virus that Causes COVID-19
Letters in Drug Design & Discovery Pharmacological Inhibition of MMP3 as a Potential Therapeutic Option for COVID-19 Associated Acute Respiratory Distress Syndrome
Infectious Disorders - Drug Targets Metabolism-based Drug-drug Interactions in Patients with Chronic Respiratory Diseases: A Review Focusing on Drugs Affecting the Respiratory System
Current Drug Metabolism COVID-19 Improved Diagnoses Based on the Open-morphology Filter and Deep-learning
Recent Patents on Engineering The Immunomodulatory Effects of Physical Activity
Current Pharmaceutical Design Antiviral Activity of Natural and Synthetic Brassinosteroids
Current Medicinal Chemistry - Anti-Infective Agents